Pfizer Inc. (NYSE:PFE) Q2 2024 Earnings Conference Call July 30, 2024 10:30 AM ETCompany ParticipantsFrancesca DeMartino – Chief Investor Relations Officer ...

Despite the topline growth during the quarter, Pfizer’s net income also dropped 98% to $41 million, while its adjusted diluted earnings per share (EPS) slid 11% to $0.60. In light of its quarterly ...

Pfizer is positioning for a potential long-term rebound following a steep post-COVID revenue decline and a drop of over 50% ...

Pfizer (PFE) reported Q2 results that exceeded estimates. The pharmaceutical and biotech major reported adjusted diluted earnings of $0.60 per share in the second quarter, a decline of 11% year ...

Pfizer (PFE) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.67 per share a year ago.

We think PFE stock may see higher levels post Q3 announcement on a revenue and earnings beat. If the company were to raise its full-year outlook, it will likely bode well with the investors.

Pfizer's stock fell 2.4% following its Q2 results on July 28, even as the company topped earnings and revenue expectations and nudged its annual earnings outlook slightly higher.